Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. The company has a strategic partnership with ClearPoint Neuro Inc. for the development of ClearPoint Prism, a Neuro Laser Therapy System. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Frequently asked questions
What sector does Clinical Laserthermia Systems AB (publ) (CLS-B) operate in?
Clinical Laserthermia Systems AB (publ) belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Clinical Laserthermia Systems AB (publ) (CLS-B) current stock price?
As of the latest data, Clinical Laserthermia Systems AB (publ) stock price is SEK 1.88, with a previous close of SEK 1.89. Clinical Laserthermia Systems AB (publ) lost -SEK 0.01 in the last trading session, representing a -0.63% loss.
What is Clinical Laserthermia Systems AB (publ) (CLS-B) current market capitalization?
Clinical Laserthermia Systems AB (publ) market cap is approximately 59.13 million.
What is Clinical Laserthermia Systems AB (publ) (CLS-B) Earnings Per Share (EPS)?
The trailing EPS is -SEK 1.29.
What is Clinical Laserthermia Systems AB (publ) (CLS-B) EBITDA?
Clinical Laserthermia Systems AB (publ) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -11.42 million.
Does Clinical Laserthermia Systems AB (publ) (CLS-B) pay dividends?
No. Clinical Laserthermia Systems AB (publ) does not pay a dividend.
What is Clinical Laserthermia Systems AB (publ) (CLS-B) beta (volatility) score?
Clinical Laserthermia Systems AB (publ) has a beta of -0.090, indicating lower volatility than the overall market.
